Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents

MLA

Jiao-Lan Qin, et al. “Design, Synthesis and Pharmacological Evaluation of New 3-(1H-Benzimidazol-2-Yl)Quinolin-2(1H)-One Derivatives as Potential Antitumor Agents.” European Journal of Medicinal Chemistry, vol. 157, Sept. 2018, pp. 139–50. EBSCOhost, https://doi.org/10.1016/j.ejmech.2018.07.066.

APA

Jiao-Lan Qin, Hong Liang, Lu Xing, Zhen-Feng Chen, Bi-Qun Zou, Ri-Zhen Huang, Wen-Bin Kuang, Ye Zhang, & Qi-Pin Qin. (2018). Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents. European Journal of Medicinal Chemistry, 157, 139–150. https://doi.org/10.1016/j.ejmech.2018.07.066

Chicago

Jiao-Lan Qin, Hong Liang, Lu Xing, Zhen-Feng Chen, Bi-Qun Zou, Ri-Zhen Huang, Wen-Bin Kuang, Ye Zhang, and Qi-Pin Qin. 2018. “Design, Synthesis and Pharmacological Evaluation of New 3-(1H-Benzimidazol-2-Yl)Quinolin-2(1H)-One Derivatives as Potential Antitumor Agents.” European Journal of Medicinal Chemistry 157 (September): 139–50. doi:10.1016/j.ejmech.2018.07.066.